Close Menu
    Irani KhabarIrani Khabar
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Irani KhabarIrani Khabar
    Home » As COVID-19 cases soar again in China, cremations are rising
    Health

    As COVID-19 cases soar again in China, cremations are rising

    December 22, 2022
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    The Chinese government has already prepared for an inevitable spike in deaths related to COVID-19 following the reversal of Beijing’s “zero-COVID” policy. In response to widespread protests, the government loosened its restrictions, which many in the country believe contributed to the death of ten people in a fire that occurred in a high-rise apartment building.

    As COVID-19 cases soar again in China, cremations are risingAs cases soared, China’s health care system was caught unprepared and scrambling to find beds and medicines to maintain clinics. There have been tens of thousands of fever clinics added to hospitals and even sports arenas in major cities throughout China, including Beijing, Shanghai, Chengdu, and Wenzhou. Asymptomatic cases are no longer reported by officials.

    Experts have already predicted that China could experience more than one million COVID-related deaths next year. According to Our World in Data, a spike occurred in March of this year with a rolling average of 26,570. The current wave peaked at 40,791 cases with a high of 62,439 on Dec. 2. Prior to the rollback of zero-COVID, WHO Emergencies Director Mike Ryan argued that “the control measures in themselves were not stopping the disease.”

    There is a significant lack of vaccinations in China, which contributes to the difficulty. As of December, China was delivering 100,000 to 200,000 doses per day. As of Dec. 13, that number had risen to more than 1.43 million. For years, China refused to adopt vaccines from the West. Instead, it relied on a vaccine called Sinopharm that doesn’t use mRNA models. These introduce antigen templates without exposing people to real viruses. Compared to older vaccine models, the more recent vaccines also scale and produce faster.

    China has approved the Pfizer-BioNTech vaccine for use, with the first batch being sent out Wednesday. There were no details on the size or timing of the delivery. Currently, the vaccine is only available to Germans living in China, but Beijing plans to use it for Chinese nationals as well. The country has around 20,000 Germans. As an exchange, Chinese citizens in Germany can receive SinoVac.

    Related Posts

    Kisangani hub active as DR Congo launches Ebola vaccination

    August 29, 2026

    EU expands Ebola response with €2.1 million PCR tests

    August 25, 2026

    Australian team finds new way to tackle triple-negative breast cancer

    August 22, 2026

    DR Congo secures 70,000 doses for Ebola outbreak

    August 21, 2026

    Congo Ebola outbreak passes 5,000 cases as response grows

    August 19, 2026

    DRC malaria toll nears 30,000 deaths after 26 million cases

    August 17, 2026
    Latest News

    Messi ends Argentina career with 207 caps and 125 goals

    September 1, 2026

    China digital industry revenue and profit rise in first half

    September 1, 2026

    UN says violence against children off track for 2030

    September 1, 2026

    Japan stocks slide as Nikkei falls and bond yields rise

    September 1, 2026

    Indonesia expands sports investment under licensing pact

    August 31, 2026

    India Uzbekistan partnership expands with 11 agreements

    August 31, 2026

    919 dead, 4,793 missing after Nepal-Tibet floods

    August 31, 2026

    Sichuan tremor as magnitude 5.1 earthquake strikes Longchang

    August 29, 2026
    © 2026 Irani Khabar | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.